1. Home
  2. JILL vs PLX Comparison

JILL vs PLX Comparison

Compare JILL & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo J. Jill Inc.

JILL

J. Jill Inc.

HOLD

Current Price

$12.31

Market Cap

188.7M

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.09

Market Cap

159.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JILL
PLX
Founded
1959
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
188.7M
159.5M
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
JILL
PLX
Price
$12.31
$2.09
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$17.00
$12.00
AVG Volume (30 Days)
49.8K
817.2K
Earning Date
06-10-2026
05-12-2026
Dividend Yield
2.42%
N/A
EPS Growth
N/A
N/A
EPS
1.82
0.22
Revenue
$596,549,000.00
$52,744,000.00
Revenue This Year
$2.65
$36.81
Revenue Next Year
N/A
N/A
P/E Ratio
$6.73
$9.32
Revenue Growth
N/A
N/A
52 Week Low
$10.41
$1.34
52 Week High
$18.80
$3.19

Technical Indicators

Market Signals
Indicator
JILL
PLX
Relative Strength Index (RSI) 48.26 52.20
Support Level $12.02 $2.06
Resistance Level $12.71 $2.16
Average True Range (ATR) 0.60 0.13
MACD 0.04 0.02
Stochastic Oscillator 41.86 76.03

Price Performance

Historical Comparison
JILL
PLX

About JILL J. Jill Inc.

J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). J.Jill caters to a distinctive set of women, typically forty-five years and older, offering them various apparel products, footwear, and accessories, comprising shirts, dresses, tops and tees, sweaters, pants and jeans, jewelry, bags, belts, shoes, scarves, etc. The company's operating segments consist of its Retail channels, which derive maximum revenue, and Direct channels. Geographically, the majority of its revenue is derived from the United States.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: